97 related articles for article (PubMed ID: 22277129)
1. Disruption of CTCF at the miR-125b1 locus in gynecological cancers.
Soto-Reyes E; González-Barrios R; Cisneros-Soberanis F; Herrera-Goepfert R; Pérez V; Cantú D; Prada D; Castro C; Recillas-Targa F; Herrera LA
BMC Cancer; 2012 Jan; 12():40. PubMed ID: 22277129
[TBL] [Abstract][Full Text] [Related]
2. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
Lai AY; Fatemi M; Dhasarathy A; Malone C; Sobol SE; Geigerman C; Jaye DL; Mav D; Shah R; Li L; Wade PA
J Exp Med; 2010 Aug; 207(9):1939-50. PubMed ID: 20733034
[TBL] [Abstract][Full Text] [Related]
4. CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer.
Kemp CJ; Moore JM; Moser R; Bernard B; Teater M; Smith LE; Rabaia NA; Gurley KE; Guinney J; Busch SE; Shaknovich R; Lobanenkov VV; Liggitt D; Shmulevich I; Melnick A; Filippova GN
Cell Rep; 2014 May; 7(4):1020-9. PubMed ID: 24794443
[TBL] [Abstract][Full Text] [Related]
5. Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo.
Gilsbach R; Schwaderer M; Preissl S; Grüning BA; Kranzhöfer D; Schneider P; Nührenberg TG; Mulero-Navarro S; Weichenhan D; Braun C; Dreßen M; Jacobs AR; Lahm H; Doenst T; Backofen R; Krane M; Gelb BD; Hein L
Nat Commun; 2018 Jan; 9(1):391. PubMed ID: 29374152
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions.
Menigatti M; Staiano T; Manser CN; Bauerfeind P; Komljenovic A; Robinson M; Jiricny J; Buffoli F; Marra G
Oncogenesis; 2013 Jul; 2(7):e56. PubMed ID: 23857251
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Silencing by DNA Methylation in Human Cancer: a Literature Analysis.
Strmsek Z; Kunej T
Noncoding RNA; 2015 Apr; 1(1):44-52. PubMed ID: 29861414
[TBL] [Abstract][Full Text] [Related]
8. Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems.
Schuyler RP; Merkel A; Raineri E; Altucci L; Vellenga E; Martens JHA; Pourfarzad F; Kuijpers TW; Burden F; Farrow S; Downes K; Ouwehand WH; Clarke L; Datta A; Lowy E; Flicek P; Frontini M; Stunnenberg HG; Martín-Subero JI; Gut I; Heath S
Cell Rep; 2016 Nov; 17(8):2101-2111. PubMed ID: 27851971
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer plasticity and epigenomics in the acquisition of a stem-like phenotype.
Berry NB; Bapat SA
J Ovarian Res; 2008 Nov; 1():8. PubMed ID: 19025622
[TBL] [Abstract][Full Text] [Related]
10. CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53.
Saldaña-Meyer R; González-Buendía E; Guerrero G; Narendra V; Bonasio R; Recillas-Targa F; Reinberg D
Genes Dev; 2014 Apr; 28(7):723-34. PubMed ID: 24696455
[TBL] [Abstract][Full Text] [Related]
11. Quantifying mRNA and microRNA with qPCR in cervical carcinogenesis: a validation of reference genes to ensure accurate data.
Leitão Mda C; Coimbra EC; de Lima Rde C; Guimarães Mde L; Heráclio Sde A; Silva Neto Jda C; de Freitas AC
PLoS One; 2014; 9(11):e111021. PubMed ID: 25365304
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
Logan M; Hawkins SM
Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of miR-203 in endometrial carcinomas.
Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics in ovarian cancer.
Seeber LM; van Diest PJ
Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
[TBL] [Abstract][Full Text] [Related]
15. Role of Flavonoids as Epigenetic Modulators in Cancer Prevention and Therapy.
Fatima N; Baqri SSR; Bhattacharya A; Koney NK; Husain K; Abbas A; Ansari RA
Front Genet; 2021; 12():758733. PubMed ID: 34858475
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic DNA Modifications Upregulate SPRY2 in Human Colorectal Cancers.
Stuckel AJ; Zeng S; Lyu Z; Zhang W; Zhang X; Dougherty U; Mustafi R; Zhang Q; Joshi T; Bissonnette M; Choudhury SR; Khare S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685612
[TBL] [Abstract][Full Text] [Related]
17. Targeting the epigenome in in-stent restenosis: from mechanisms to therapy.
Yang X; Yang Y; Guo J; Meng Y; Li M; Yang P; Liu X; Aung LHH; Yu T; Li Y
Mol Ther Nucleic Acids; 2021 Mar; 23():1136-1160. PubMed ID: 33664994
[TBL] [Abstract][Full Text] [Related]
18. MiRNAs: A Powerful Tool in Deciphering Gynecological Malignancies.
Duică F; Condrat CE; Dănila CA; Boboc AE; Radu MR; Xiao J; Li X; Creţoiu SM; Suciu N; Creţoiu D; Predescu DV
Front Oncol; 2020; 10():591181. PubMed ID: 33194751
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets.
Xu J; An P; Winkler CA; Yu Y
Front Oncol; 2020; 10():1271. PubMed ID: 32850386
[TBL] [Abstract][Full Text] [Related]
20. The Regulatory Roles of Non-coding RNAs in Angiogenesis and Neovascularization From an Epigenetic Perspective.
Hernández-Romero IA; Guerra-Calderas L; Salgado-Albarrán M; Maldonado-Huerta T; Soto-Reyes E
Front Oncol; 2019; 9():1091. PubMed ID: 31709179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
